Skip to main content
profile image
Selected Works of Carlo B. Bifulco, M.D.
Article
Immunoscore predicts significant differences in time to recurrence in stage I colon cancer patients
Annals of Oncology (2019)
  • J. Galon, Paris Descartes University
  • F. Hermitte, Medical Affairs, HalioDx, Marseille, France
  • B. Mlecnik, Paris Descartes University
  • F. Marliot, Laboratory of Immunology, AP-HP, Georges Pompidou European Hospital, Paris, France
  • C. Bifulco, Providence Portland Medical Center
  • A. Lugli, University of Bern
  • I. Nagtegaal, Radboud University Nijmegen
  • A. Hartmann, Department of Surgery, University Erlangen-Nürnberg, Erlangen, Germany
  • M. van den Eynde, Department of Medical Oncology, Cliniques Universitaires St. Luc, Brussels, Belgium
  • M. Roehrl, Memorial Sloan Kettering Cancer Center
  • P. Ohashi, Princess Margaret Cancer Centre
  • E. Zavadova, Charles University in Prague
  • T. Torigoe, Sapporo Medical University
  • P. Patel, Cancer Biology, The Gujarat Cancer & Research Institute, Ahmedabad, India
  • Y. Wang, Xi'an Jiaotong University
  • Y. Kawakami, Keio University
  • F. Marincola, Refuge Biotechnologies, Refuge Biotechnologies, Menlo Park, USA
  • P. Ascierto, Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Instituto Nazionale Tumori – I.R.C.C.S - Fondazione Pascale, Naples, Italy
  • B. Fox, Laboratory of Molecular and Tumor Immunology, Earle A. Chiles Research Institute at the Robert W. Franz Cancer Center, Portland, OR, USA
  • F. Pagès, Laboratory of Immunology, AP-HP, Georges Pompidou European Hospital, Paris, France
Link
Disciplines
Publication Date
November 1, 2019
DOI
10.1093/ANNONC/MDZ421
Citation Information
J. Galon, F. Hermitte, B. Mlecnik, F. Marliot, et al.. "Immunoscore predicts significant differences in time to recurrence in stage I colon cancer patients" Annals of Oncology Vol. 30 (2019)
Available at: http://works.bepress.com/carlo-bifulco/61/